Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 80.65% vs -41.01% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 108.32% vs 24.54% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -5.48% vs 3.50% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 112.46% vs 65.93% in Mar 2024
Compare Profit and Loss Results of Anlon Healthcare
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
120.00
405.00
-285.00
-70.37%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
120.00
405.00
-285.00
-70.37%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-17.00
20.00
117.65%
Raw Materials Consumed
71.00
149.00
-78.00
-52.35%
Power & Fuel Cost
2.00
11.00
-9.00
-81.82%
Employee Cost
4.00
96.00
-92.00
-95.83%
Operating Expenses
2.00
29.00
-27.00
-93.10%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
23.00
-22.00
-95.65%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
26.00
-25.00
-96.15%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
88.00
356.00
-268.00
-75.28%
Operating Profit (PBDIT) excl Other Income
32.00
49.00
-17.00
-34.69%
Other Income
0.00
4.00
-4.00
-100.00%
Operating Profit (PBDIT)
32.00
53.00
-21.00
-39.62%
Interest
3.00
10.00
-7.00
-70.00%
Profit before Depriciation and Tax
28.00
43.00
-15.00
-34.88%
Depreciation
1.00
9.00
-8.00
-88.89%
Profit Before Taxation & Exceptional Items
26.00
33.00
-7.00
-21.21%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
26.00
33.00
-7.00
-21.21%
Provision for Tax
6.00
9.00
-3.00
-33.33%
Profit After Tax
20.00
23.00
-3.00
-13.04%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2.00
155.00
-153.00
-98.71%
Profit Available for appropriations
22.00
179.00
-157.00
-87.71%
Appropriations
22.00
179.00
-157.00
-87.71%
Equity Dividend (%)
0%
50%
-50.00
Earnings Per Share
6.37
2.6
3.77
145.00%
Profit And Loss - Net Sales
Net Sales 120.29 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 80.65% vs -41.01% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 108.32% vs 24.54% in Mar 2024
Profit And Loss - Interest
Interest 3.72 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.48% vs 3.50% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 20.52 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 112.46% vs 65.93% in Mar 2024






